A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Conditions
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV) · Idiopathic Inflammatory Myositis (IIM) · Systemic Sclerosis (SSc) · Systemic Lupus Erythematosus (SLE) · Lupus Nephritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Wallace Rheumatic Center, Beverly Hills, California, United States
Providence Medical Foundation, Fullerton, California, United States
University of California Irvine, Irvine, California, United States
Children's Hospital Los Angeles Division Of Rheumatology, Los Angeles, California, United States
University of California San Francisco, San Francisco, California, United States
University of Florida, Gainesville, Florida, United States
Nicklaus Children's Hospital, Miami, Florida, United States
University of Louisville, Louisville, Kentucky, United States
University of Minnesota Medical School, Minneapolis, Minnesota, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Montefiore Medical Center, New York, New York, United States
Duke University Health System, Durham, North Carolina, United States
MetroHealth, Cleveland, Ohio, United States
University of Oklahoma, Oklahoma City, Oklahoma, United States
Jefferson Einstein Hospital Philadelphia, Philadelphia, Pennsylvania, United States
Regional One Health, Memphis, Tennessee, United States
Hôpital La Pitié Salpêtrière, Paris, France
Uppsala University, Uppsala, Uppland, Sweden
Manchester University NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
University College of London Hospitals NHS Trust (UCLH), London, United Kingdom